Eléments de l'association

	Région Centre	157
	Sylvie Chalon	19
	Région Centre *Sauf* Sylvie Chalon"	140
	Sylvie Chalon *Sauf* Région Centre"	2
	Région Centre Et Sylvie Chalon	17
	Région Centre Ou Sylvie Chalon	159
	*Corpus*	9014

List of bibliographic references

Number of relevant bibliographic references: 17.

Ident.	Authors (with country if any)	Title
000297	Mine Silindir Gunay [Turquie, France] ; A. Yekta Ozer [Turquie] ; Sylvie Chalon [France]	Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
001260	Serge Maia [France] ; Nicolas Arlicot [France] ; Emilie Vierron [France] ; Sylvie Bodard [France] ; Jackie Vergote [France] ; Denis Guilloteau [France] ; Sylvie Chalon [France]	Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6‐hydroxydopamine rat model of Parkinson's disease
001994	Emmanuelle Lagrue [France] ; Hiroyuki Abe [France, Japon] ; Madakasira Lavanya [France, États-Unis] ; Jawida Touhami [France] ; Sylvie Bodard [France] ; Sylvie Chalon [France] ; Jean-Luc Battini [France] ; Marc Sitbon [France] ; Pierre Castelnau [France]	Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport
002500	Gaëlle Bouchez [France] ; Luc Sensebe [France] ; Patrick Vourc'H [France] ; Lucette Garreau [France] ; Sylvie Bodard [France] ; Angélique Rico [France] ; Denis Guilloteau [France] ; Pierre Charbord [France] ; Jean-Claude Besnard [France] ; Sylvie Chalon [France]	Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease
002504	Patrick Emond [France] ; Denis Guilloteau [France] ; Sylvie Chalon [France]	PE21 : A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter
002653	Wadad Saba [France] ; Héric Valette [France] ; Marie-Anne Schöllhorn-Peyronneau [France] ; Christine Coulon [France] ; Michele Ottaviani [France] ; Sylvie Chalon [France] ; Frédéric Dolle [France] ; Patrick Emond [France] ; Christer Halldin [Suède] ; Julie Helfenbein [France] ; Jean-Claude Madelmont [France] ; Jean-Bernard Deloye [France] ; Denis Guilloteau [France] ; Michel Bottlaender [France]	[11C]LBT‐999: A suitable radioligand for investigation of extra‐striatal dopamine transporter with PET
002817	Emmanuelle Lagrue [France] ; Sylvie Chalon [France] ; Sylvie Bodard [France] ; Elie Saliba [France] ; Pierre Gressens [France] ; Pierre Castelnau [France]	Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice
002F92	Paula Ravenscroft [Royaume-Uni] ; Sylvie Chalon [France] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni]	Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia
003067	Caroline Prunier [France] ; Erwan Bézard ; Jérôme Montharu ; Marina Mantzarides ; Jean-Claude Besnard ; Jean-Louis Baulieu ; Christian Gross ; Denis Guilloteau ; Sylvie Chalon	Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.
003231	Caroline Prunier [France] ; Pierre Payoux [France] ; Denis Guilloteau [France] ; Sylvie Chalon [France] ; Bruno Giraudeau [France] ; Cynthia Majorel [France] ; Mathieu Tafani [France] ; Erwan Bezard [France] ; Jean-Paul Esquerre [France] ; Jean-Louis Baulieu [France]	Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease
003315	Christelle Gouhier [France] ; Sylvie Chalon ; Anne Aubert-Pouessel ; Marie-Claire Venier-Julienne ; Christophe Jollivet ; Jean-Pierre Benoit ; Denis Guilloteau	Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
003477	Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France]	Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat
003D62	Sylvie Chalon [France] ; Patrick Emond [France] ; Sylvie Bodard [France] ; Marie-Paule Vilar [France] ; Cynthia Thiercelin [France] ; Jean-Claude Besnard [France] ; Denis Guilloteau [France]	Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease
003F95	Guylène Pagea [France] ; Sylvie Chalon [France] ; Laurence Barrier [France] ; Alain Piriou [France] ; François Huguet [France]	Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools
004079	Denis Guilloteau [France] ; Patrick Emond [France] ; Jean-Louis Baulieu [France] ; Lucette Garreau [France] ; Yves Frangin [France] ; Léandre Pourcelot [France] ; Laurent Mauclaire [France] ; Jean-Claude Besnard [France] ; Sylvie Chalon [France]	Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative ( E )- N -(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I)
004348	Patrick Emond [France] ; Sylvie Chalon [France] ; Lucette Garreau [France] ; Anne-Marie Dognon [France] ; Sylvie Bodard [France] ; Yves Frangin [France] ; Jean-Louis Baulieu [France] ; Jean-Claude Besnard [France] ; Dennis Guilloteau [France]	A new iodinated tropane derivative (β‐CDIT) for in vivo dopamine transporter exploration: Comparison with β‐CIT
004590	Christian Pellevoisin [France] ; Denis Guilloteau [France] ; Jean-Louis Baulieu [France] ; Christian Loc'H [France] ; Anne-Marie Dognon [France] ; Laurent Mauclaire [France] ; Jean-Claude Saccavini [France] ; Jean-Claude Besnard [France] ; Sylvie Chalon [France]	Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors: A comparative study

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024